NCT00078728

Brief Summary

This study will evaluate the effectiveness of a short-term family-based program for preventing anxiety disorders in at-risk children.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2003

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2003

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

March 5, 2004

Completed
3 days until next milestone

First Posted

Study publicly available on registry

March 8, 2004

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2007

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2007

Completed
6.5 years until next milestone

Results Posted

Study results publicly available

December 16, 2013

Completed
Last Updated

February 7, 2018

Status Verified

January 1, 2018

Enrollment Period

3.8 years

First QC Date

March 5, 2004

Results QC Date

October 24, 2013

Last Update Submit

January 29, 2018

Conditions

Keywords

Anxiety

Outcome Measures

Primary Outcomes (2)

  • Number of Children With Child Anxiety Diagnosis

    Measured by the Anxiety Disorder Interview Schedule for the Diagnostic and Statistical Manual of Mental Disorders 4th edition, child and parent versions.

    12 month

  • Child Anxiety Diagnoses

    The cumulative number of children who developed an anxiety disorder at each assessment point during the study. Using the intent to treat sample, a total of 6 children in the non-intervention group developed an anxiety disorder by the 12-month assessment. No children in the CAPS group developed an anxiety disorder.

    12 months

Study Arms (2)

Family-based anxiety prevention program

EXPERIMENTAL

Participants will complete an 8 session (1 session/week), cognitive behavioral therapy-based, family prevention program to be administered by a trained clinician, after randomization to the study. The prevention program will include 3 booster sessions that take place after the first 8 sessions.

Behavioral: Family-Based Anxiety Prevention Program

Evaluation only

ACTIVE COMPARATOR

Waitlist control group. Participants in this group will receive general information (in the form of a printed packet) about anxiety after randomization to the study. Families in this group will complete all study evaluations and will then be offered the option of participating in the prevention program. Families who accept will begin the prevention sessions and will receive the same CBT-based, family-based prevention program as the other treatment arm.

Behavioral: Evaluation only

Interventions

Participants in the prevention program will have weekly sessions with a therapist and will learn skills to help reduce anxiety for 8 weeks. The intervention will begin immediately after randomization to the study.

Family-based anxiety prevention program
Evaluation onlyBEHAVIORAL

Participants will undergo evaluations without active treatment for 8 weeks.

Evaluation only

Eligibility Criteria

Age7 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Mothers with a current, primary anxiety disorder
  • year old children without an anxiety disorder

You may not qualify if:

  • Mothers that do not have a current, primary anxiety disorder
  • year old children with an anxiety disorder
  • year old children that are currently receiving treatment for anxiety that could interfere with the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Johns Hopkins University School of Medicine

Baltimore, Maryland, 21205, United States

Location

MeSH Terms

Conditions

Anxiety Disorders

Condition Hierarchy (Ancestors)

Mental Disorders

Limitations and Caveats

Of the 40 participants in the study, no adverse events occured or were reported.

Results Point of Contact

Title
Golda Ginsburg, PhD,Professor
Organization
The Johns Hopkins University School of Medicine

Study Officials

  • Golda S. Ginsburg, PhD

    Johns Hopkins University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 5, 2004

First Posted

March 8, 2004

Study Start

September 1, 2003

Primary Completion

July 1, 2007

Study Completion

July 1, 2007

Last Updated

February 7, 2018

Results First Posted

December 16, 2013

Record last verified: 2018-01

Locations